Ironwood Pharmaceuticals Inc. Receives $50,000,000 New Financing

  • Feed Type
  • Date
  • Company Name
    Ironwood Pharmaceuticals Inc.
  • Mailing Address
    320 Bent Street Cambridge, MA 02141
  • Company Description
    We are committed to the development of successful human medicines. Drugmaking is not a statistical event, nor simply a high-throughput industrialized pursuit. Our team is forging a process for creating and developing novel drug candidates that integrates the most successful drugmaking practices of the past and the best of today’s cutting-edge technologies. Our efficient discovery and development processes, focused on important human needs, are generating a robust pipeline.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    This infusion of equity capital will enable us to execute on our comprehensive development plans for linaclotide, which has the potential to benefit millions of patients; advance our pipeline of therapeutic candidates; and grow our sales and marketing team to commercialize our products.
  • M&A Terms
  • Venture Investor
    Morgan Stanley Venture Partners
  • Venture Investor
    Ridgeback Capital
  • Venture Investor
    Fidelity BioSciences
  • Venture Investor
    Paperboy Ventures
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor

Trending on Xconomy